MediFransk ApS: Financial statements 2022
CVR: 40780904
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MediFransk ApS (CVR 40780904) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 608,378 and a net result of DKK -8,997 compared with DKK 2,498 the year before. That is an increase of 33.3% compared with the year before. Equity in the 2022 report amounted to DKK 33,411. The solvency ratio was 16.8%.
- Gross Profit
- DKK 608,378
- Profit/Loss
- DKK -8,997
- Equity
- DKK 33,411
- Total Assets
- DKK 199,221
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 608 t. | -9 t. | 33 t. | - |
| 2021 | - | 457 t. | 2 t. | 42 t. | - |
Official annual report
Keep an eye on MediFransk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MediFransk ApS has published its annual report for 2021. Gross profit came to DKK 456,553, and the net result was DKK 2,498.
About MediFransk ApS
MediFransk ApS is a Danish company of the type Anpartsselskab based in Ålsgårde, founded in 2019. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Frédéric Pierre Louis Bernard. The company is owned by BERNARD Holding ApS. In 2025, the company reported a gross profit of DKK 485,515 and a net result of DKK 104,261 compared with DKK 50,715 the year before. Equity in the 2025 report amounted to DKK 174,291.